may not prevent a violation of this section. Adherence to those guidelines does not constitute a defense. C. The presence of more than one NSAID may constitute a NSAID stacking violation consistent with the following restrictions: (1) A Class 1 NSAID Stacking Violation (Penalty Class B) occurs when: (a) Two non-steroidal anti-inflammatory are found at individual levels determined to exceed the following restrictions: (i) 5 nanograms per milliliter of plasma or serum; Diclofenac – (ii) Firocoxib - 20 nanograms per milliliter of plasma or (iii) Flunixin 20 nanograms per milliliter of plasma or serum; – (iv) Ketoprofen 2 nanograms per milliliter of plasma or – (v) Phenylbutazone 5 micrograms per milliliter of plasma or – serum; or (vi) all other non-steroidal anti-inflammatory drugs – laboratory concentration of detection. (b) Three or more non-steroidal anti-inflammatory drugs are found at individual levels determined to exceed the following restrictions: (i) Diclofenac 5 nanograms per milliliter of plasma or serum; – (ii) Firocoxib - 20 nanograms per milliliter of plasma or serum; (iii) Flunixin 3 nanograms per milliliter of plasma or – (iv) Ketoprofen 1 nanograms per milliliter of plasma or serum; – (v) Phenylbutazone 0.5 micrograms per milliliter of plasma – or serum; or (vi) all other non-steroidal anti-inflammatory drugs – laboratory concentration of detection. (2) A Class 2 NSAID Stacking Violation (Penalty Class C) occurs when: (a) Any one substance in Subsection (1)(a) above is found in excess of the restrictions contained therein in combination with any one of the following substances at levels below the restrictions so noted but in excess of the following levels:
may not prevent a violation of this section. Adherence to those guidelines does not constitute a defense. C. The presence of more than one NSAID may constitute a NSAID stacking violation consistent with the following restrictions: (1) A Class 1 NSAID Stacking Violation (Penalty Class B) occurs when: (a) Two non-steroidal anti-inflammatory are found at individual levels determined to exceed the following restrictions: (i) Diclofenac – 5 nanograms per milliliter of plasma or serum; (ii) Firocoxib - 20 nanograms per milliliter of plasma or (iii) Flunixin – 20 nanograms per milliliter of plasma or serum; (iv) Ketoprofen – 2 nanograms per milliliter of plasma or (v) Phenylbutazone – 5 micrograms per milliliter of plasma or serum; or (vi) all other non-steroidal anti-inflammatory drugs – laboratory concentration of detection. (b) Three or more non-steroidal anti-inflammatory drugs are found at individual levels determined to exceed the following restrictions: (i) Diclofenac – 5 nanograms per milliliter of plasma or serum; (ii) Firocoxib - 20 nanograms per milliliter of plasma or serum; (iii) Flunixin – 3 nanograms per milliliter of plasma or (iv) Ketoprofen – 1 nanograms per milliliter of plasma or serum; (v) Phenylbutazone – 0.5 micrograms per milliliter of plasma or serum; or (vi) all other non-steroidal anti-inflammatory drugs – laboratory concentration of detection. (2) A Class 2 NSAID Stacking Violation (Penalty Class C) occurs when: (a) Any one substance in Subsection (1)(a) above is found in excess of the restrictions contained therein in combination with any one of the following substances at levels below the restrictions so noted but in excess of the following levels:
017c011.docx